Mr. Chair, Madame Findlay, I would first like, with your agreement, to make a comment on the release of the report you had in support of what Deputy Gourde said, and then turn to Shereen Miller, director general of OSME, to answer the question related to the role in comparison to what is happening with the U.S. government in the presentation.
I just want to recall from what has been said that we are in the process of the final quality assurance review of three documents, or three pieces that we did commit to release, not only to the committee but to the industry. We expect to do that via MERX, or in the best way that's it's accessible to all. We committed to that through the business rationale related to GENS for the consultation we undertook. These are the results of that consultation, a summary of what we've heard, along with recommendations, because it's one thing to consult, but we need to analyze and see how we can take action in response to suggestions that were made by the industry.
I also want to point out--and you'll see this--that one of the main concerns you have heard at the committee related to the GENS initiative was with the inclusion of a whole array of professional services as part of the request for proposal procurement process. We've heard it, and I'm pleased to report that we are making proposals to remove the majority of the professional services as part of the scope of work for that requirement.